Fluco axapharm 50 mg

Fluco axapharm 50 mg is a medicine authorised by Swissmedic under authorisation number 69977. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 December 2025 and the authorisation is limited until 09 December 2030. ATC code J02AC01 places the medicine in the group Antimycotics for systemic use.

  • Dispensing category B
  • Authorisation number 69977
  • ATC J02AC01
  • Synthetic medicines
Authorisation data
Authorisation number69977
NameFluco axapharm 50 mg
Full nameFluco axapharm 50 mg, Hartkapseln
Authorisation holderaxapharm ag
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeJ02AC01
First authorisation10 December 2025
Authorisation validity09 December 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Fluco axapharm 50 mg, HartkapselnB10 December 2025
2Fluco axapharm 150 mg, HartkapselnB10 December 2025
3Fluco axapharm 200 mg, HartkapselnB10 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
17Kapsel(n)J02AC0108.06.0.B
228Kapsel(n)J02AC0108.06.0.B
31Kapsel(n)J02AC0108.06.0.B
44Kapsel(n)J02AC0108.06.0.B
52Kapsel(n)J02AC0108.06.0.B
67Kapsel(n)J02AC0108.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fluco axapharm 50 mg authorised in Switzerland?

Yes. Fluco axapharm 50 mg is authorised by Swissmedic under authorisation number 69977, data as of 01 September 2026. The authorisation is limited until 09 December 2030.

Which dispensing category does Fluco axapharm 50 mg have?

Fluco axapharm 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fluco axapharm 50 mg?

The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com